4//SEC Filing
Harper Sean E 4
Accession 0001127602-18-020733
CIK 0000318154other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 7:07 PM ET
Size
5.6 KB
Accession
0001127602-18-020733
Insider Transaction Report
Form 4
AMGEN INCAMGN
Harper Sean E
EVP, Research & Development
Transactions
- Sale
Common Stock
2018-06-12$184.27/sh−1,525$281,012→ 57,510 total
Footnotes (3)
- [F1]The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
- [F2]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 3,000 RSUs which vest in installments of 1,477 5/3/2019 and 1,523 on 5/3/2020; 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 398 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001541946
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 7:07 PM ET
- Size
- 5.6 KB